BRAF Mutation in Thyroid Cancer | UCLA Endocrine Center

Dr. Michael Yeh, UCLA Health endocrine surgeon, discusses the importance of the BRAF V600E mutation in thyroid cancer, and how it influences both treatment and prognosis. Learn more about services at the UCLA Endocrine Center: https://www.uclahealth.org/medical-se...